Zantac Recall

Zantac Recall


On April 1, 2019, the Food and Drug Administration (FDA) recalled all prescription and over-the-counter Zantac (Ranitidine) drugs from the market. This was the latest step in a long running investigation related to contaminated Zantac. The FDA determined that the contaminate known as N-Nitrosodimethylamine (NDMA) increased over time and when stored at room temperatures may expose consumers to unacceptable levels of NDMA.

NDMA is a known human carcinogen – meaning is could cause cancer. Lawsuits claim that Zantac cause the following types of cancer:

  • Bladder Cancer
  • Colorectal Cancer
  • Esophageal Cancer
  • Intestinal Cancer
  • Kidney Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Stomach Cancer
  • Testicular Cancer
  • Uterine or Ovarian Cancer

Yaeger Law is investigating cases in which patients took Zantac or generic forms of Rantidine and then developed certain cancers. If you or a loved one experienced injuries related to Zantac, you may be entitled to compensation. Contact Yaeger Law to discuss the details of your potential Zantac Lawsuit.


11/19/2019: Precision Dose recalls ranitidine oral solution, USP 150 mg/10 ml due to potential presence of n-nitrosodimethylamine (NDMA) above levels established by the FDA.

11/15/2019: Golden State Medical Supply (GSMS, Inc.) recalls ranitidine HCl 150mg and 300mg capsules due to potential presence of n-nitrosodimethylamine (NDMA) above levels established by the FDA.

11/8/2019: Amneal Pharmaceuticals recalls ranitidine tablets, 150 mg and 300 mg, and ranitidine syrup (ranitidine oral solution, USP), 15 mg/ml due to due to potential n-nitrosodimethylamine (NDMA) amounts above levels established by the FDA.

11/8/2019: American Health Packaging recalls ranitidine liquid unit dose cups due to NDMA impurity.

11/6/2019: Aurobindo & DG Health recalls ranitidine due to NDMA impurity.

10/25/2019: Novitium Pharma recalls ranitidine hydrochloride capsules 150 mg and 300 mg because it may contain n-nitrosodimethylamine (NDMA).

10/25/2019: Lannett Company, Inc. recalls ranitidine syrup (ranitidine oral solution, USP), 15mg/ml due to above levels of NDMA.

10/23/2019: Dr. Reddy’s, Kroger, Walgreens, and others recall ranitidine tablets & capsules for containing N-Nitrosodimethylamine (NDMA).

10/23/2019: Perrigo Company plc recalls Ranitidine (all pack sizes) for the presence of N-Nitrosodimethylamine (NDMA).

10/22/2019: Sanofi recalls all Zantac OTC products in the U.S. for possibly containing N-Nitrosodimethylamine (NDMA).

9/25/2019: Apotex Corp. recalls 75mg and 150mg ranitidine tablets for containing a nitrosamine impurity called N-nitrosodimethylamine (NDMA)

9/23/2019: Sandoz Inc. recalled ranitidine hydrochloride capsules due to an elevated amount of an unexpected impurity, N-nitrosodimethylamine (NDMA)

contact us for a free consultation

Yaeger Law

Yaeger Law, PLLC   |  727-202-5015  |  [email protected]

The information on this website is not legal advice and does not create an attorney-client relationship. The information on this website is for general purposes only and should not be interpreted to indicate a certain result will occur in your specific legal situation. No representation is made that the quality of the legal services to be performed is greater than the quality of legal services performed by other lawyers. Prior results do not guarantee a similar outcome.


Yaeger Law is ready to partner with you. We are accepting new co-counsel arrangements in pending and prospective complex litigation cases, including mass torts and personal injury matters. We focus on individual details of cases to maximize recovery and provide excellent client service. You will have transparency that will allow you to follow our effort on each case.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from - Youtube
Consent to display content from - Vimeo
Google Maps
Consent to display content from - Google
Skip to content